Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquiredrttnews·2 days ago, 10:34 PMFBRX-0.16%TVGNW-9.35%
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition PotentialTip Ranks·2 days ago, 11:55 AMTRAX+5.00%FBRX-0.16%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·2 days ago, 07:05 AMMPLT+22.01%MTNB+1.67%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC-8.85%HYFT-4.41%
Capital Moves Take Center Stage: From AutoZone's Massive Buyback to Biotech DebutsGlobal Report·Jul 14 at 06:47 AMAZO+0.75%TRAX+5.00%
First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.benzinga_article·Jul 10 at 11:34 AMTRAX+5.00%
Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLTrttnews·Jul 10 at 07:21 AMTRAX+5.00%MPLT+22.01%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 9 at 12:05 PMVRAX+1.38%IONS-2.28%
Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and VitiligoTip Ranks·Jul 8 at 08:25 AMTRAX+5.00%
Top Biotech Gainers: ABVX Soars On UC Trial Data, PMN Eyes Alzheimer's Catalyst, TRAX In Focusrttnews·Jun 30 at 09:45 PMTRAX+5.00%SSII-2.04%
AnaptysBio subleases 45,057 sq ft San Diego office space to First Tracks BiotherapeuticsPUBT·Jun 22 at 03:06 PMTRAX+5.00%ANAB+6.00%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jun 11 at 04:05 PMRDHL-6.47%INAB-3.60%
